Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
109 studies found for:    prodromal
Show Display Options
Rank Status Study
1 Withdrawn C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation
Condition: Hereditary Angioedema
Interventions: Drug: C-1-esterase;   Drug: placebo
2 Completed Glycine Treatment of Prodromal Symptoms
Condition: Schizophrenia
Intervention: Drug: glycine
3 Unknown  Psychological Intervention for Persons in the Early Initial Prodromal State
Conditions: Schizophrenia;   Psychosis
Interventions: Behavioral: Cognitive behavioral therapy (CBT);   Behavioral: Supportive Counselling (SC)
4 Active, not recruiting Dose-Finding Study To Evaluate the Safety and Tolerability of E2609 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
Conditions: Alzheimer Disease;   Dementia, Alzheimer Type
Interventions: Drug: elenbecestat (E2609);   Drug: Placebo
5 Active, not recruiting Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: Verubecestat (Part I and Part II);   Other: Placebo (Part I);   Other: Verubecestat (Part II)
6 Terminated A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Avagacestat;   Drug: Placebo
7 Completed Aripiprazole Treatment of Prodromal Patients
Conditions: Schizophrenia;   Psychosis
Intervention: Drug: Aripiprazole
8 Completed A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: JNJ-54861911 10 mg;   Drug: JNJ-54861911 50 mg;   Drug: Placebo
9 Not yet recruiting Aging Stereotypes and Prodromal Alzheimer's Disease
Condition: Mild Cognitive Impairment (MCI)
Intervention: Diagnostic Test: Diagnosis of MCI versus No MCI (SCI or healthy patient)
10 Active, not recruiting A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
11 Completed Isotopic Imaging for Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Intervention:
12 Unknown  Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
Condition: Granulin Mutation
Interventions: Drug: FRM-0334;   Drug: Placebo
13 Recruiting CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
14 Active, not recruiting A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Gantenerumab;   Drug: Placebo
15 Active, not recruiting Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb);   Drug: Placebo
16 Recruiting A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
17 Completed Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Conditions: Schizophrenia;   Psychoses
Interventions: Behavioral: Supportive management;   Drug: Amisulpride
18 Completed Ethyl-EPA Treatment of Prodromal Patients
Condition: Schizophrenia Prodrome
Intervention: Drug: ethyl-eicosapentaenoic acid
19 Enrolling by invitation VX15/2503 Treatment for Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: VX15/2503;   Drug: Placebo
20 Completed " The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Other: Neuropsychological assessment;   Other: ophthalmologic checkup;   Other: Automated non-invasive oculometry

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.